FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Infinium Pharmachem IPO and Sancode Technologies IPO.
Infinium Pharmachem IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Sancode Technologies IPO is a SME Fixed Price Issue proposed to list at BSE SME.
Infinium Pharmachem IPO | Sancode Technologies IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Fixed Price Issue |
Listing At | NSE SME | BSE SME |
Lead Managers | Swastika Investmart Ltd | Shreni Shares Limited |
Registrar | Bigshare Services Pvt Ltd | Bigshare Services Pvt Ltd |
Market Maker | Swastika Investmart Limited | Shreni Shares Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Infinium Pharmachem IPO is up to ₹25.26 Cr whereas the issue size of the Sancode Technologies IPO is up to ₹5.15 Cr. The final issue price of Infinium Pharmachem IPO is ₹135.00 per share and of Sancode Technologies IPO is ₹47.00 per share.
Infinium Pharmachem IPO | Sancode Technologies IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ||
Issue Price (Upper) | ||
Issue Price (Final) | ₹135.00 per share | ₹47.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹13.50 per share | |
Market Lot Size | 1000 shares | 3000 shares |
Fresh Issue Size | 18,75,000 shares | 10,95,000 shares |
Fresh Issue Size (Amount) | up to ₹25.26 Cr | up to ₹5.15 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 18,75,000 shares | 10,95,000 shares |
Issue Size Total (Amount) | up to ₹25.26 Cr | up to ₹5.15 Cr |
Infinium Pharmachem IPO opens on Mar 31, 2023, while Sancode Technologies IPO opens on Mar 31, 2023. The closing date of Infinium Pharmachem IPO and Sancode Technologies IPO is Apr 05, 2023, and Apr 06, 2023, respectively.
Infinium Pharmachem IPO | Sancode Technologies IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Mar 31, 2023 | Mar 31, 2023 |
Issue Close | Apr 05, 2023 | Apr 06, 2023 |
Basis Of Allotment (Tentative) | Apr 11, 2023 | Apr 12, 2023 |
Initiation of Refunds (Tentative) | Apr 12, 2023 | Apr 13, 2023 |
Credit of Share (Tentative) | Apr 13, 2023 | Apr 17, 2023 |
Listing date (Tentative) | Apr 17, 2023 | Apr 18, 2023 |
Anchor Lockin End date 1 | May 11, 2023 | May 12, 2023 |
Anchor Lockin End date 2 | Jul 10, 2023 | Jul 11, 2023 |
Infinium Pharmachem IPO P/E ratio is 7.83, as compared to Sancode Technologies IPO P/E ratio of 10.71.
Infinium Pharmachem IPO | Sancode Technologies IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | 97.47% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 73.05% | 71.24% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 7.83 | 10.71 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹93.93 Cr. | ₹19.12 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Infinium Pharmachem IPO retail investors (RII) are offered 9,37,500 shares while in Sancode Technologies IPO retail investors are offered 9,37,500 shares. Qualified institutional buyers (QIB) are offered 0 shares in Infinium Pharmachem IPO and 0 shares in Sancode Technologies IPO.
Infinium Pharmachem IPO | Sancode Technologies IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | 94,000 shares | 57,000 shares |
QIB | 0 shares | 0 shares |
NII | 9,37,500 shares | 5,19,000 shares |
RII | 9,37,500 shares | 5,19,000 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 18,75,000 shares | 10,38,000 shares |
Infinium Pharmachem IPO subscribed 1.84x in total, whereas Sancode Technologies IPO subscribed 3.68x.
Infinium Pharmachem IPO | Sancode Technologies IPO | |
---|---|---|
QIB (times) | ||
NII (times) | 1.80x | 3.98x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 1.86x | 3.39x |
Employee (times) | ||
Other (times) | ||
Total (times) | 1.84x | 3.68x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|